News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
550,767 Results
Type
Article (45510)
Company Profile (145)
Press Release (505112)
Section
Business (155626)
Career Advice (2402)
Deals (29508)
Drug Delivery (107)
Drug Development (68629)
Employer Resources (149)
FDA (15984)
Job Trends (12409)
News (277521)
Policy (30257)
Tag
Academia (2356)
Alliances (39586)
Alzheimer's disease (1293)
Approvals (15889)
Artificial intelligence (129)
Bankruptcy (311)
Best Places to Work (9467)
Biotechnology (90)
Breast cancer (119)
Cancer (1068)
Cardiovascular disease (99)
Career advice (2007)
Cell therapy (232)
Clinical research (54353)
Collaboration (359)
Compensation (200)
COVID-19 (2594)
C-suite (91)
Data (1047)
Diabetes (152)
Diagnostics (6369)
Drug pricing (97)
Earnings (60577)
Employer resources (137)
Events (79506)
Executive appointments (278)
FDA (16519)
Funding (307)
Gene therapy (187)
GLP-1 (645)
Government (3851)
Healthcare (15364)
Infectious disease (2683)
Inflammatory bowel disease (101)
Interviews (445)
IPO (14200)
Job creations (3279)
Job search strategy (1678)
Layoffs (453)
Legal (7042)
Lung cancer (171)
Manufacturing (177)
Medical device (11648)
Medtech (11651)
Mergers & acquisitions (15381)
Metabolic disorders (438)
Neuroscience (1569)
NextGen Class of 2024 (5153)
Non-profit (3331)
Northern California (1368)
Obesity (258)
Opinion (190)
Patents (103)
People (44793)
Phase I (16214)
Phase II (23542)
Phase III (19307)
Pipeline (456)
Postmarket research (2225)
Preclinical (6610)
Radiopharmaceuticals (222)
Rare diseases (226)
Real estate (4574)
Regulatory (20717)
Research institute (2154)
Resumes & cover letters (402)
Southern California (1170)
Startups (2923)
United States (12135)
Vaccines (620)
Weight loss (213)
Date
Today (71)
Last 7 days (620)
Last 30 days (3490)
Last 365 days (32667)
2024 (30004)
2023 (36204)
2022 (46606)
2021 (50245)
2020 (47358)
2019 (37776)
2018 (28709)
2017 (29175)
2016 (27461)
2015 (30226)
2014 (23690)
2013 (19516)
2012 (20907)
2011 (21400)
2010 (19318)
Location
Africa (710)
Arizona (150)
Asia (32113)
Australia (5594)
California (2990)
Canada (1018)
China (192)
Colorado (131)
Connecticut (150)
Europe (77897)
Florida (427)
Georgia (105)
Illinois (279)
Indiana (156)
Maryland (540)
Massachusetts (2348)
Michigan (127)
Minnesota (256)
New Jersey (870)
New York (871)
North Carolina (700)
Northern California (1368)
Ohio (115)
Pennsylvania (754)
South America (1073)
Southern California (1170)
Texas (406)
Utah (90)
Washington State (330)
550,767 Results for "bioporto diagnostics a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioPorto A/S to Host Third Quarter 2024 Earnings Webcast
November 12, 2024
·
2 min read
Press Releases
BioPorto A/S Announces Changes to the US Commercial Organization
October 22, 2024
·
2 min read
Press Releases
BioPorto is proud to have Nine of the top-ten best US Children’s hospitals as customers of NGAL
October 22, 2024
·
4 min read
Press Releases
BioPorto Sponsors Exhibits to Showcase Launch of ProNephro AKI in the U.S. and Ongoing Marketing of The NGAL Test to Clinicians at Major Healthcare Conferences
November 11, 2024
·
5 min read
Press Releases
BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024
November 14, 2024
·
6 min read
Press Releases
BioPorto Enters Global Distribution Partnership with Beckman Coulter for Acute Kidney Injury NGAL Tests
October 29, 2024
·
4 min read
News
BioPorto Presenting FDA-cleared ProNephro AKI (NGAL) at ASN Kidney Week 2024 Conference
October 23, 2024
·
4 min read
Press Releases
BioPorto A/S to Host Second Quarter 2024 Earnings Webcast & Investor Meeting
August 7, 2024
·
2 min read
Press Releases
First Patient In - BioPorto Initiates Patient Enrollment for US Study of ProNephro AKI (NGAL)™ for Adult Use at Massachusetts General Hospital
October 29, 2024
·
5 min read
Press Releases
BioPorto Announces Interim Results and Business Update for the Second Quarter and Six Months of Fiscal 2024
August 15, 2024
·
7 min read
1 of 55,077
Next